AVENCORA Trademark

Trademark Overview

On Friday, November 21, 2025, a trademark application was filed for AVENCORA with the United States Patent and Trademark Office. The USPTO has given the AVENCORA trademark a serial number of 79441773. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, January 26, 2026. This trademark is owned by Boehringer Ingelheim International GmbH. The AVENCORA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of prevention and treatment of kidney diseases and inflammatory diseases; providing medical and scientific research information in the field of kidney diseases and inflammatory diseases.
avencora

General Information

Serial Number79441773
Word MarkAVENCORA
Filing DateFriday, November 21, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, January 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific research in the field of prevention and treatment of kidney diseases and inflammatory diseases; providing medical and scientific research information in the field of kidney diseases and inflammatory diseases.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 22, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Thursday, January 22, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 23, 2026APPLICATION FILING RECEIPT MAILED
Saturday, January 24, 2026ASSIGNED TO EXAMINER
Monday, January 26, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

avencora diseases inflammatory scientific kidney field research information medical providing treatment